Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "amgen rank"

Top 7 Research Reports for July 29, 2016
Zacks.com

Top 7 Research Reports for July 29, 2016

Today's must-read reports are for Amgen (AMGN), JPMorgan (JPM) and Mondelez (MDLZ). Zacks Rank # 2 (Buy) rated Amgen's strong Q2 earnings report earlier this week - it beat on the top- and bottom-lines and guided higher - has helped the stock's ... Yahoo! Canada, 2 months ago
Top Research Reports for September 2, 2016 Yahoo! Canada, 3 weeks ago
CB Insights - Corporate VC 2016 SlideShare.net, 4 weeks ago
[x]  

Amgen, Biogen, Gilead Could Skirt California Measure

A California ballot initiative requiring the state's Medicaid arm to buy drugs at comparable prices to what the U.S. Department of Veterans Affairs pays could backfire, thus preserving sales for the nation's biggest drugmakers, RBC analyst Michael ...
 Investor's Business Daily10 hours ago
Freshnews.com

Amgen, Novartis AG's Migraine Drug Successful in Phase III Study

Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study - Pivotal ARISE Study of Erenumab in Episodic Migraine Prevention Met Primary Endpoint - People With Episodic Migraine ...
 BioSpace14 hours ago Amgen Reports Positive Results For Erenumab From A Phase 3 Study  RTTNews.com1 day ago AMGEN : Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study  4 Traders1 day ago Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study  PipelineReview17 hours ago
[x]  
Nasdaq

Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III

Biotech major, Amgen, Inc. AMGN announced that its multiple myeloma drug Kyprolis did not meet the primary endpoint in a phase III head-to-head CLARION study with Velcade. The CLARION study (n=955) compared Kyprolis (carfilzomib) in combination ...
 Yahoo! Singapore1 day ago Amgen Inc. (AMGN) Is Down After Phase 3 Study Of Multiple Myeloma Drug Failed  RTTNews.com2 days ago Amgen Says Phase 3 CLARION Study In Multiple Myeloma Fails To Meet Primary Goal  RTTNews.com2 days ago
[x]  

Amgen Investor Conference Call At 8:30 AM ET

Amgen Inc. (AMGN) will host a conference call at 8:30 AM ET on September 27, 2016, to discuss the CLARION data. To access the live webcast, log on at http://investors.amgen.com/phoenix.zhtml-c=61656&p=irol-eventDetails&EventId=5237507 by RTT ...
 RTTNews.com2 days ago Amgen Analyst Meeting At 11:30 AM ET  RTTNews.com1 week ago Amgen Inc.'s (AMGN): Investor's Watch List  Equilibrio Informativo1 week ago
Zacks.com

Biosimilars in Limelight on FDA Approval of Amgen Drug

Late last week, the FDA approved yet another biosimilar product -- biotech giant Amgen Inc.'s ( AMGN - Analyst Report ) Amjevita (adalimumab-atto). Amjevita has been approved for use in all eligible indications of the reference product, AbbVie ...
 Zacks.com2 days ago FDA Okays Amgen's AMJEVITA For Treatment Of Seven Inflammatory Diseases  RTTNews.com4 days ago
[x]  
Nasdaq

Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval

Amgen, Inc. AMGN today announced the approval of Amjevita (adalimumab-atto), a biosimilar version to AbbVie Inc.'s ABBV rheumatoid arthritis (RA) drug Humira. Amjevita has been approved for the same indications that Humira is being used for ...
 Yahoo! Singapore3 days ago FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE  RTTNews.com3 days ago
[x]  
Financial Express

Dr Reddy's to market 3 Amgen drugs in India

To address needs in areas of oncology, osteoporosis Hyderabad, Sept 16: Pharma major Dr Reddy's Laboratories Ltd has expanded its collaboration with Amgen in India to market and distribute three of the latter's medicines in the domestic ...
 Hindu Business Line1 week ago Dr Reddy's inks pact with US-based Amgen to market three drugs in India  Firstpost.com1 week ago Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in India  Economic Times1 week ago DRL inks pact with Amgen to market three drugs in India  Financial Express1 week ago
Nasdaq

Pharmaceuticals Newsletter - September 12 to 16, 2016 [India Infoline News Service]

Top News Dr. Reddy's expands strategic collaboration with Amgen in India Dr. Reddy's Laboratories announced that it has expanded its strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and ...
 Pharmacy Choice1 week ago Dr. Reddy's collaborates with Amgen to commercialize its products in India  EHealth Magazine1 week ago Dr. Reddy's Expands Strategic Collaboration with Amgen in India  Equity Bulls1 week ago Dr. Reddy's Laboratories Ltd.???s Expands Strategic Collaboration With Amgen In India  BioSpace1 week ago
[x]  
Nasdaq

Guide to American Funds American Mutual F1 Fund (AMFFX)

American Funds American Mutual F1 Fund (AMFFX) a Zacks Rank #2 (Buy) as incepted in February 1950 and is managed by Capital Research and Management Company. The objective of AMFFX is to provide for the balanced accomplishment of three objectives ...
 Yahoo! Finance1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less